Oishii Plus Co. Ltd. announced that it has raised in a round of funding on May 18, 2023. the transaction included participation from new investor, Rohto Pharmaceutical Co.,Ltd.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,995 JPY | -5.76% | -1.64% | +5.35% |
Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.35% | 4.64B | |
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Oishii Plus Co. Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd.